CNS Drug Delivery

Precision delivery for complex therapies

Precision delivery means defining where, when, and how a therapy reaches and acts in the central nervous system (CNS); by aligning the drug delivery device, the therapy, and the target biology to achieve an intentional, predictable, and safe effect.

Developing therapies for the central nervous system brings a unique challenge. Success depends not just on the therapy, but on how it is delivered.

Formulation and device groups are often working through difficult questions;

• How to reach the target in the right quantities?
• How to reduce risk?
• How to build evidence that stands up in the clinic?

Our focus is practical; clear answers to difficult questions, at the stage they matter most.

The challenge with CNS delivery and product development

CNS therapies place high demands on delivery systems

Viral vectors and cell therapies often need targeted delivery to specific regions. Small changes in placement, flow or pressure can affect both efficacy and safety.

In contrast, many large molecules require broad distribution across CNS spaces to achieve therapeutic effect.

This creates a different but equally demanding challenge. Both must ensure consistent distribution, procedural reliability, and patient safety while minimizing off-target effects.

The challenge goes beyond the device

Successful CNS delivery depends on the full system working together: the therapy, target biology, route of administration, anatomy, and clinical workflow.

These factors interact in ways that are difficult to predict and must be carefully integrated to achieve safe, reproducible, and effective delivery.

We help clients answer these questions and navigate device design and development earlier in therapy development.

Bringing together in-depth CNS insight, in silico and tissue based modelling and design and engineering, we support the right decisions, earlier in development.

How we accelerate your product development

We support teams at the points where uncertainty is highest, answering key questions.

Where do we start?

Identifying gaps

We map data mismatch and prioritize risks.  Assessing the scientific landscape and defining what matters most for development.

Bridging science to clinic

Enabling translation

We connect modelling, testing and clinical intent into a clear development pathway.

What “good” looks like

Prioritizing needs

We translate therapy needs into product, procedure and testing strategies.

From confidence to proof

Planning verification

We develop structured approaches that combine modelling, analysis and physical testing.

Our CNS Drug Delivery Services

Scientific and medical research

• Identify gaps in evidence and development risks
• Assess anatomical and route constraints
• Identify relevant physiological considerations
• Engage clinicians and subject matter experts
• Support early decision making

Translational planning and preclinical development

• Translate therapeutic needs into delivery requirements
• Explore biodistribution and route considerations
• Connect in vitro, in silico and in vivo work
• Develop concepts and characterization plans

Verification strategy and execution

• Create multi-modal verification plans
• Develop test methods and engineering analysis
• Combine modelling with physical testing
• Support readiness for technical documentation

Why work with CDP

Effective CNS delivery requires integrated science, engineering, and clinical expertise. We help clients to:

• Make better early technical decisions
• Reduce delivery and translational risk
• Turn uncertainty into feasible and structured development
• Prepare therapy delivery for progression to clinic

Uncertain how delivery will impact your CNS therapy, let us help you define the right next step.